Package 69423-964-08

{"route": ["ORAL"], "spl_id": "402e337c-3129-96ea-e063-6294a90ad155", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0323900039780"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1369842"], "spl_set_id": ["d3bfce81-9e6d-6741-e053-2a95a90af183"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "236 mL in 1 BOTTLE, PLASTIC (69423-964-08)", "package_ndc": "69423-964-08", "marketing_start_date": "20201001"}], "brand_name": "Vicks Formula 44 VapoCool Cough and Chest Congestion", "product_id": "69423-964_402e337c-3129-96ea-e063-6294a90ad155", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "69423-964", "generic_name": "acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin", "labeler_name": "The Procter & Gamble Manufacturing Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vicks Formula 44", "brand_name_suffix": "VapoCool Cough and Chest Congestion", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "650 mg/30mL"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/30mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/30mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/30mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}